The inhibitor of VEGF receptor tyrosine kinase was introduced in detail. 详细介绍了VEGF受体酪氨酸激酶(TYK)抑制剂的研究进展。
The progress in tyrosine kinase inhibitor has been reviewed, including the chemical structures and the pharmacophore models. 本文综述了近年来酪氨酸激酶(TYK)抑制剂的研究进展,包括抑制剂的结构和与激酶作用的药效团模型。
Erlotinib is a small molecule tyrosine kinase inhibitor that efficiently blocks EGFR. 厄洛替尼是一种小分子的酪氨酸激酶(TYK)抑制剂,它能有效地阻断EGFR的作用。
Objective : To study the abnormity of tyrosine kinase signaling pathway in different prognosis patients with lung adenocarcinoma. 目的:探讨不同预后的肺腺癌患者在酪氨酸激酶(TYK)信号传导通路上的具体差异。